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Aim: The present study aimed to investigate the possible influence of nasopharyngeal preoperative or postoperative tramadol instillation
on postoperative pain and agitation in pediatric patients undergoing adenoidectomy, with or without tonsillectomy and tube placement.
Materials and methods: Ninety pediatric patients were included in the study. Induction of anesthesia was achieved with 2.5 mg kg−1
propofol and 0.6 mg kg−1 rocuronium bromide. To maintain the anesthesia, 2%–2.5% sevoflurane in an oxygen-N2O mixture (FiO2 =
35%) was administered. In Group I (n = 30), 1 mg kg−1 tramadol was given 10 min before adenoidectomy, and in Group II (n = 30) it
was administered 10 min after adenoidectomy was achieved on the adenoid tissue. Saline, at the same volume, was injected as a control
in Group III (n = 30). Patients were evaluated for postoperative pain, agitation score, and modified Aldrete score (MAS) in recovery.
Results: When compared with the treatment groups, pain scores and analgesic requirements in the control group significantly increased
(P < 0.001). Agitation scores were also significantly higher in the same group. Time-related MASs were significantly lower in the control
group in the early recovery period.
Conclusion: Preoperative or postoperative tramadol instillation administered to the adenoidectomy area significantly decreased
postoperative analgesic requirements and agitation.
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1. Introduction
Adenoidectomy and tonsillectomy operations are
among the most frequent surgeries performed for the
pediatric population in an outpatient setting. Pain in the
postoperative period remains the major determinant of
morbidity and should be reduced without increasing the
side effects. Surgery is performed in the preschool period
in the great majority of patients, and there is a prominent
incidence of volatile anesthetic-induced agitation (1).
Sevoflurane is the volatile anesthetic of choice in the
pediatric population due to its smooth mask induction and
early recovery profile properties. Emergence agitation is
the phenomenon largely linked with the use of sevoflurane.
Although it can also be observed without surgery,
such as in imaging studies, pain seems to be one of the
contributing factors (2). Agitation may influence surgical
outcomes by delaying discharge, increasing complications,
and consuming the time of the recovery staff.
Tramadol is considered a weak opioid analgesic that
also has serotonin and noradrenaline reuptake inhibition
(3). It is also suggested for postoperative pain relief after
* Correspondence: alpaslanapan@gmail.com

minor surgeries because of its local anesthetic properties
(4). Drop formulation is one of the commercially available
forms of the drug. Tramadol has been largely investigated
to determine the doses of intravenous (i.v.) or peritonsillar
infiltration for postoperative pain relief in pediatric
patients undergoing adenoidectomy or tonsillectomy (5–
8). Although mucosal application is associated with faster
peak plasma concentrations with long-lasting analgesic
levels (9), there are limited data about its clinical use in
this regard.
The absorption of tramadol after oral administration
was demonstrated to be faster in a study investigating the
pharmacokinetics of the oral form of the drug in pediatric
patients aged 4 to 7 years. The peak plasma level was
reached at about 30 min and the analgesic concentration,
considered as 100 ng mL−1, was maintained throughout 6.8
h. The faster metabolism of pediatric patients and active
metabolites that augment µ-receptor affinity were cited as
factors that contributed to this increased effect (9). When
compared with the placebo, tramadol ointment in a dose
of 3 mg kg−1 before dental intervention was demonstrated
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to provide marked analgesia in pediatric patients without
respiratory depression (10). Although a lower dose was
applied at the surgical site, effective analgesia was also
observed in our study by means of decreasing supplemental
analgesics and agitation in the postoperative period, with
similar recovery profiles.
The objectives of this study were to investigate
tramadol instillation to the adenoid tissue before or after
surgical ablation versus a placebo and to compare the
postoperative analgesic effects and possible influence on
agitation in pediatric patients undergoing adenoidectomy
and/or tonsillectomy, with or without tube placement.
2. Materials and methods
This prospective, randomized, placebo-controlled study
was performed after obtaining approval from the Local
Ethics Committee and informed consent from parents or
caregivers (No: 2009-206). The study was conducted in the
Anesthesiology and Otorhinolaryngology Departments of
the Kırıkkale University School of Medicine from January
2010 to March 2011.
Ninety pediatric patients, aged between 3 and 16 years
and with American Society of Anesthesiologists (ASA)
physical status I or II, were allocated to 3 groups, each
group containing 30 patients.
Patients with chronic systemic disorders such as
renal insufficiency, respiratory disease, or heart failure;
neurological or psychiatric disorders that influence
cognition; use of analgesics within the 2 days before the
surgery; a known allergy to the study drugs; or parental
refusal were excluded from the study. Randomization was
performed using shuffled opaque envelopes chosen before
the surgery.
Patients received 0.5 mg kg−1 oral midazolam in 20 mL
of strawberry juice 30 min before arrival to the holding
area. Venous access was performed on the dorsum of the
hand after applying EMLA cream (ASTRA, Södertajle,
Sweden) and a solution containing 1/3 glucose with saline
mixture was started at a dose of 4 mL kg−1 h−1. Patients
were monitored, including an electrocardiogram at
V5, noninvasive blood pressure measurements, oxygen
saturation, body temperature, and end-tidal CO2 after
intubation. The other anesthetic gas concentrations were
followed continuously and recorded every 5 min (DatexOhmeda Cardiocap 5, Helsinki, Finland).
The induction of anesthesia was achieved with
2.5 mg kg−1 propofol containing 1 mg mL−1 lidocaine
and 0.6 mg kg−1 rocuronium bromide. Endotracheal
intubation was performed with an appropriate reinforced
tube and sevoflurane with an end-tidal concentration
of 2%–2.5% in an oxygen-N2O mixture (FiO2 = 35%)
was administered for maintenance. Unless otherwise
indicated, a muscle relaxant was administered only during
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the induction. Sevoflurane concentration was adjusted
according to the heart rate or blood pressure values in
order to maintain them within limits of approximately
10% of the preoperative measurements. Patients were
mechanically ventilated with a tidal volume of 8 mL kg−1
and the frequency was adjusted to maintain an end-tidal
CO2 level of around 4–4.5 kPa. Patients were positioned
for surgery and an oral retractor was applied. A solution
of 1 mg kg−1 tramadol was administered 10 min before
(Group I) as a preemptive treatment or 10 min after
bleeding control was achieved (Group II), or an equal
volume of saline was administered to the adenoid tissue
10 min before adenoidectomy (Group III controls) while
the uvula was retracted using an insulin injector (1 mL =
100 U) extended with a 20-G prefilled i.v. cannula without
an introducer. The injectors were filled with an undiluted
form of the tramadol (100 mg = 1 mL) or saline in units
corresponding to the body weights. Tonsillectomy or
tube placements were performed after adenoidectomy
and all surgeries were performed by the same technique.
The study drugs and controls were prepared in a separate
room by an investigator who did not participate in any
of the later observations. Residual muscle relaxation was
antagonized using 10 µg kg−1 atropine sulfate with 30
µg kg−1 neostigmine. Endotracheal tubes were removed
according to the objective criteria of the extubation (able
to hold head and neck up for at least 5 s, squeeze hand,
protrude tongue) and adequate respiration (tidal volume ≥
6 mL kg−1, respiratory rate > 10 breaths min−1) after suction
was performed with care. Respiratory complications
including bronchospasm, laryngospasm, or cough and
other complications such as nausea, vomiting, or bleeding
from surgical sites were recorded. Patients were observed
while supplemental oxygen at 2–3 L min−1 was maintained
with a mask until cooperation was achieved, and they
were then transferred to the recovery room. Patients were
monitored and vital findings were recorded every 5 min
and oxygen was continued until discharge to the ward.
Pain was assessed using a verbal rating scale (VRS)
scored between 0 (no pain) to 10 (worst pain imaginable)
every 1 h for the first 4 h. An intravenous infusion of
paracetamol, at a dose of 10 mg kg−1, was given in cases
of VRS ≥ 4, which were treated with 5 or 10 mg i.v.
meperidine (according to body weights of ≤30 kg or
>30 kg), repeated if required. Agitation was assessed by
an independent observer during the recovery period as
according to Aono et al. (1) and scored as: 1 = calm, 2 = not
calm but easily calmed, 3 = moderately agitated or restless,
and 4 = combatively excited or disoriented. A modified
Aldrete score (MAS) (11) was recorded during the same
period, and complications or side effects in the recovery
room were also noted. Patients were accepted as eligible
to transfer to the ward when there was no complication
such as nausea, vomiting, cardiovascular instability, or
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respiratory insufficiency within the past 30 min and
patients were calm, sitting, and staying unaided according
to their age. Patients were discharged following the
surgical visit on the same day when patients were calm and
cooperative, pain scores were decreased, and there was no
bleeding from the surgical site. A telephone interview was
performed with parents 24 h after the operation in order to
determine whether there were further complications, like
sleep disturbance or problems with food or fluid intake.
2.1. Statistical analysis
Statistical analyses were performed using a package
program (SPSS for Windows 15.0, SPSS Inc., Chicago,
IL, USA). Our preliminary data indicated that at least 26
patients were required to determine any difference between
supplemental analgesic consumption within 24 h with an
α of 0.05 and β of 90%. Each group therefore consisted of
30 patients, to account for possible dropouts. Side effect
profiles and differences including sex or ASA physical

status were evaluated using contingency tables and chisquare and Fisher exact tests. Continuous variables were
analyzed using 1- or 2-way ANOVA and with repeated
measures when indicated, followed by Tukey’s test for
post hoc comparison. The Mann–Whitney U test and
Bonferroni correction were used for nonparametric data.
A P-value of less than 0.05 was considered as statistical
significant.
3. Results
All patients were eligible to complete the study and were
included in the further analyses. Groups were similar
with respect to age, weight, and sex distribution and ASA
physical status, except that height was higher in Group III
(P < 0.05) when compared with the other groups (Table 1).
The indications for surgery and duration of surgery and
anesthesia are shown in Table 2. The study groups were
comparable according to these variables.

Table 1. Patient demographics and American Society of Anesthesiologists (ASA)
physical status, *: P < 0.05.

Age (years)
Height (cm)
Weight (kg)
Sex (F/M)
ASA status (I/II)

Group I
(n = 30)

Group II
(n = 30)

Group III
(n = 30)

7.2 ± 2.6
107 ± 16
25.5 ± 10.9
16/14
28/2

5.6 ± 3.1
103.3 ± 23.8
21.1 ± 8.6
12/18
29/1

7.4 ± 3.5
122.3 ± 21.4*
27 ± 13.6
13/17
28/2

Table 2. Operation indications and periods of anesthesia, surgery, recovery, and pain scales, *: P < 0.05.

Types of surgery
A
T
A+T
A + TP
Duration of anesthesia (min)
Duration of operation (min)
Time to open eyes (min)
Time to consolation (min)
Time to cooperation (min)
VRS 0
VRS 1
VRS 2
VRS 3
VRS 4

Group I
(n = 30)

Group II
(n = 30)

Group III
(n = 30)

15
3
5
7
55.5 ± 26.5
48.9 ± 23.8
6.2 ± 3.2
8.9 ± 3.8
15.9 ± 9.4
1.7 ± 1.4
1.3 ± 1.0
0.9 ± 0.7
0.6 ± 0.6
0.4 ± 0.6

9
3
11
7
54.1 ± 20.8
49.8 ± 19.7
7.4 ± 3.5
11.2 ± 5.8
16 ± 7.2
2.1 ± 1.3
1.6 ± 1.0
1.3 ± 0.9
0.9 ± 0.7
0.5 ± 0.7

16
2
8
4
51.9 ± 20.2
39.2 ± 19.5
13.8 ± 5.1
7.9 ± 3.2
19.9 ± 6.3
4.3 ± 1.8*
2.9 ± 1.4*
1.8 ± 0.9*
1.3 ± 0.6*
1.0 ± 0.6*

A: Adenoidectomy, T: tonsillectomy, TP: tube placement, VRS: verbal rating scales.
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There were no hemodynamic alterations, including
heart rate or mean arterial blood pressure, that required
medication during the surgery or in the early postoperative
period. There was no significant difference between the
study groups (data not shown).
Analgesic requirement in the postoperative period was
significantly increased in the control group, and 16 patients
received paracetamol and/or meperidine treatment in
this group. On the other hand, none of the patients in
the 2 treatment groups required additional analgesics in
the early postoperative period when compared with the
control group (P < 0.001).
Recovery profiles, including time to open eyes and time
to consolation and cooperation, were similar between the
treatment groups (Table 2). Verbal rating scales between
the study groups are also indicated in Table 2. Pain scores
were significantly higher at all time intervals in Group III
when compared with the treatment groups.
Agitation scores were significantly higher in the control
group at 0 min (P = 0.009 between Group I and Group III),
10 min (P = 0.028 between Group II and Group III), 20
min (P < 0.001 between Group I and Group III), 30 min (P
< 0.001 between Groups I and II compared to Group III),
45 min (P < 0.001 between Group I and Group III), and
4

Group I

Group II

4. Discussion
Our results indicated that tramadol instillation to the
adenoid tissue before or after the operation decreased pain,
agitation, and analgesic consumption in pediatric patients
undergoing adenoidectomy with or without tonsillectomy.
Patients in the treatment groups also had higher MAS
values, indicating that patients in these groups recovered
faster than the controls. Although a limited number of
individuals were included, this efficacy in tonsillectomy
10
9
8
7
6
5
4
3
2
1
0

Group III

Group I

Group II

Group III

MAS

Agitation score

3
2
1
0

60 min (P = 0.005 between Group I and Group III) when
compared to the preoperative and postoperative tramadol
treatment groups (Figure 1).
The MASs were significantly lower in the control group
at 0 min (P < 0.001 between Groups I and II compared to
Group III), 10 min (P < 0.001 between Groups I and II
compared to Group III), and 20 min (P < 0.01 between
Groups I and II compared to Group III). Time-related
changes in MASs are shown in Figure 2.
There was no significant difference with respect to
side effect profiles (Table 3). No further complication or
side effect, sleep disturbance, or difference in food or fluid
intake was determined in the first postoperative day via
telephone interview.
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Figure 1. Agitation scores of groups in the early postoperative
period, *: P < 0.05.

0

10

20

30
Time (min)

902

60

90

Figure 2. Modified Aldrete scores of the groups during recovery,
*: P < 0.05.

Table 3. Side effects and additional analgesic requirements of the groups, *: P < 0.001.

Laryngospasm
Throat pain
Pain on swallowing
Shivering
Nausea
Vomiting
Delirium
Additional analgesics

45

Group I
(n = 30)

Group II
(n = 30)

Group III
(n = 30)

1
3
2
1
2
1
-

1
-

1
3
1
4
16*
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patients indicates the possible spread of the drug to the
surgical area.
The analgesic effect of i.v. tramadol has been
largely investigated in pediatric patients undergoing
adenotonsillectomy, with varying success. In their study,
Ozköse et al. (5) indicated that relatively lower doses
of i.v. tramadol administration (0.5 or 1 mg kg−1) after
induction of anesthesia were found to be equally effective
for decreasing tonsillectomy pain in pediatric patients.
When compared with morphine, the analgesic effect of
tramadol for posttonsillectomy pain relief given through
a patient-controlled analgesia device was lower in the
early postoperative period, but the incidence of nausea
increased with morphine (6). Although the postoperative
analgesic effects of 1 and 2 mg kg−1 tramadol or 0.1 mg
kg−1 morphine after induction of anesthesia were found
to be comparable, the incidence of nausea and vomiting
increased with morphine (75% and 40%, respectively) in
pediatric patients undergoing tonsillectomy (7). In another
study, the analgesic effects of 0.1 mg kg−1 morphine, or 1.5
mg kg−1 tramadol given during the induction of anesthesia
were superior to those of ketamine at 0.5 mg kg−1 in
pediatric adenotonsillectomy operations (12).
Peritonsillar tramadol infiltration after tonsillectomy
was shown to be more effective than a placebo for
decreasing pain and supplemental analgesic requirements
in the early postoperative period (8). In their study,
Akkaya et al. (13) compared i.v. administration of 2 mg
kg−1 tramadol with peritonsillar infiltration, and tramadol
infiltration was determined to be superior with respect
to pain score, analgesic requirements, and side effects
including nausea and vomiting. On the other hand, this
route of administration is invasive and carries potential
complications in the postoperative period, such as
increased postoperative bleeding and respiratory distress
by compromising the airway or with inadvertent vascular
entry.
Surgical trauma leads to the dual phenomena of
peripheral and central sensitization. The result is a state
of neuronal hyperexcitability, the so-called “wind-up

phenomenon”, which could partially explain postoperative
painful states. Preemptive analgesia blocks the nociceptive
stimuli before surgery, but the timing for postoperative
analgesia is controversial. In a study of pediatric patients
undergoing hypospadias surgery, there was no significant
difference between effects of pre- and postoperative
tramadol administrations on analgesic periods or
side effect profiles (14). Our results also indicated no
additional benefit with using preemptive tramadol
before surgery. However, the facts that tramadol was well
absorbed and analgesia occurred in both of the treatment
groups indicated proper timing. In addition, the possible
influence of local anesthetic properties may influence the
outcome due to using relatively lower doses in this study.
The analgesic influence of tramadol may increase due
to the disposing site being in close vicinity to the brain.
In a previous study, our study group also demonstrated
efficacy of epidural tramadol infiltration in lumbar
microdiscectomy (15). On the other hand, addition to
the local anesthetic solution has neither influenced the
characteristics of motor and sensorial blockade nor
increased the duration of analgesia (16). These results also
indicate that the importance of the site of action might
come from pain afferents directly to the spinal cord, which
does not happen during plexus blockade. In addition to
the alleviation of pain, agitation may also decrease with the
interaction of enantiomers of tramadol on monoaminergic
and serotonergic mechanisms. The latter mechanisms
might be involved to a lesser extent in light of the higher
MAS values observed in the treatment groups, but not in
the increased agitation that might be involved with higher
doses of tramadol or interaction with other drugs (17).
The influence of tramadol on agitation and sedation will
need to be determined with further studies.
In conclusion, tramadol implementation directly to
the adenoid, before or after surgery, decreased pain and
agitation in pediatric patients undergoing adenoidectomy
with or without tonsillectomy and tube placement. This
route of tramadol administration is easy and noninvasive,
without increasing the side effects.
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